Enveric Biosciences, Inc. (ENVB) — 10-Q Filings
All 10-Q filings from Enveric Biosciences, Inc.. Browse 5 Quarterly Report reports with AI-powered summaries and risk analysis.
10-Q Filings (5)
-
Enveric Biosciences' Losses Mount Amid R&D Push, Cash Influx
— Nov 14, 2025 Risk: high
Enveric Biosciences, Inc. (ENVB) reported a net loss of $1,873,669 for the three months ended September 30, 2025, and a net loss of $6,577,816 for the nine mont -
Enveric Biosciences Files Q1 2025 10-Q
— May 14, 2025 Risk: medium
Enveric Biosciences, Inc. filed its quarterly report for the period ending March 31, 2025. The company, previously known as AMERI Holdings, Inc. and SPATIALIZER -
Enveric Biosciences Files Q3 2024 10-Q Report
— Nov 14, 2024 Risk: medium
Enveric Biosciences, Inc. filed its Q3 10-Q report for the period ending September 30, 2024. The company, formerly known as AMERI Holdings, Inc. and SPATIALIZER -
Enveric Biosciences Files Q2 2024 10-Q
— Aug 12, 2024 Risk: medium
Enveric Biosciences, Inc. filed its 10-Q for the period ending June 30, 2024. The company, previously known as AMERI Holdings, Inc. and SPATIALIZER AUDIO LABORA -
Enveric Biosciences Files 10-Q for Period Ending March 31, 2024
— May 15, 2024 Risk: low
Enveric Biosciences, Inc. (ENVB) filed a Quarterly Report (10-Q) with the SEC on May 15, 2024. Enveric Biosciences, Inc. filed a 10-Q report for the quarterly p
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX